Press Releases from NMS Group - Nerviano Medical Sciences (3 total)
SARI ANNOUNCES CLOSING OF NMS ACQUISITION
Nerviano (Milano - IT), March 28, 2018 – SARI, a Chinese market-leader biotech investment company, is pleased to announce that it has closed the previously…
SARI, a Chinese market-leader biotech investment company, today announced it has …
Nerviano (Milano), December 27, 2017 - SARI, a Chinese market-leader biotech investment company, today announced it has entered into an agreement to acquire the 90%…
Nerviano Medical Sciences presents data regarding a potent new cytotoxic molecul …
NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the nms pipeline, highly suited to conjugation with targeted antibodies.
At the 7th World…
Go To Page:
